The purpose of this study is to collect more information about how effective a combination of medications are in treating CLL in people who have not received previous treatment for their cancer.
The study drug obinutuzumab will be given as an IV infusion (through a vein in your arm). The second study drug, venetoclax, will be take by mouth at home. Study visits will include blood draws, bone marrow biopsies and/or aspirations and stool samples. We will also do CT scans or MRIs of your chest, pelvis, abdomen, and any other areas of your body that your study doctor thinks are appropriate so that we can look at and measure your disease.
study medication
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA
Christopher Jensen
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Leukemia)
21-0031